At Synergy Bioscience, we recognize that biomarker analysis is a pivotal component in the drug development process, providing essential insights into a therapeutic’s efficacy, safety, and mechanism of action. Our comprehensive biomarker analysis services play a critical role in go/no-go decision-making, target validation, and toxicity identification.

Synergy Bioscience: Precision in Biomarker Analysis

Synergy Bioscience offers an extensive array of biomarker analysis services for large molecules, small molecules, and Advanced Therapy Medicinal Products (ATMPs). Our expertise spans the entire drug development timeline, delivering precise and actionable data.

Comprehensive Biomarker Services

 Assay Development: We craft bespoke assays tailored to your therapeutic’s unique profile, ensuring sensitive and specific biomarker detection.
 Validation Services: Our validation processes adhere to the highest industry standards, confirming that our assays perform consistently under various conditions.
 Sample Analysis: We offer thorough sample analysis services, leveraging advanced techniques to provide you with detailed biomarker data.
 Extensive Biomarker Menu: Choose from over 600 off-the-shelf assays or collaborate with us to develop custom assays that meet your specific needs.

State-of-the-Art Techniques at Synergy Bioscience

 Ligand-Binding Assays: These assays are crucial for quantifying the interaction between biomolecules and their ligands, providing insights into the binding dynamics that are essential for therapeutic function.
 Cell-Based Assays: Our cell-based assays allow for the observation of cellular responses in a controlled environment, mimicking physiological conditions to predict in vivo reactions.
 Flow Cytometry: This powerful technique enables us to analyze the physical and chemical characteristics of cells or particles, providing a wealth of data on cell populations and biomarkers.
 Molecular Assays (qPCR Assays): We utilize quantitative Polymerase Chain Reaction (qPCR) assays for the precise quantification of nucleic acids, essential for gene expression analysis and molecular biomarker discovery.
 LCMS/MS: Liquid Chromatography-Mass Spectrometry (LCMS/MS) is employed for the identification and quantification of biomarkers, offering unparalleled specificity and sensitivity.

Why Choose Synergy Bioscience?

 Innovative Solutions: Our team is committed to innovation, continually advancing our techniques to stay at the forefront of biomarker analysis.
 Tailored Approach: We understand that each therapeutic is unique, and we tailor our services to fit the specific requirements of your drug development program.
 Regulatory Compliance: We ensure that all our services are compliant with regulatory standards, providing you with data that can withstand rigorous scrutiny.
 Expert Team: Our scientists and analysts are not only experts in their fields but are also passionate about contributing to the development of life-saving therapies.

By partnering with Synergy Bioscience, you’re not just choosing a service provider; you’re choosing a partner dedicated to supporting your mission of bringing safe and effective therapeutics to the market. Our commitment to quality and precision in biomarker analysis is the foundation upon which we build our partnerships, aiming to accelerate your path to success.

To discuss how Synergy Bioscience can help you, please contact us